ITPR2 and fatty liver disease: However, several works indicated that IP3R2 was a driver of senescence in human cells (20, 41–44), and ITPR2 knockout mice had suppressed Ca2+ fluxes in the MAM region and displayed less immunosenescence as well as less hepatic steatosis and fibrosis (20).